Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

Parodis I.; Ding H.; Zickert A.; Arnaud L.; Larsson A.; Svenungsson E.; Mohan C.; Gunnarsson I.

首页> 外文期刊>Scandinavian journal of rheumatology >Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

【24h】

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

机译：血清可溶性肿瘤坏死因子受体-2（STNFR2）作为肾组织损伤的生物标志物和狼疮性肾炎的长期肾果菌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: We investigated the performance of soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of renal activity, damage, treatment response, and long-term outcome in lupus nephritis (LN).

机译：目的：我们调查了可溶性肿瘤坏死因子受体-2（STNFR2）作为葡萄牙肾炎（LN）的肾脏活性，损伤，治疗反应和长期结果的生物标志物的性能。

著录项

来源
《Scandinavian journal of rheumatology》 |2017年第4期|共10页
作者
Parodis I.; Ding H.; Zickert A.; Arnaud L.; Larsson A.; Svenungsson E.; Mohan C.; Gunnarsson I.;
展开▼
作者单位

Karolinska Inst Karolinska Univ Hosp Dept Med Rheumatol Unit Stockholm Sweden;

Univ Houston Dept Biomed Engn Houston TX USA;

Karolinska Inst Karolinska Univ Hosp Dept Med Rheumatol Unit Stockholm Sweden;

Karolinska Inst Karolinska Univ Hosp Dept Med Rheumatol Unit Stockholm Sweden;

Uppsala Univ Dept Med Sci Clin Chem Uppsala Sweden;

Karolinska Inst Karolinska Univ Hosp Dept Med Rheumatol Unit Stockholm Sweden;

Univ Houston Dept Biomed Engn Houston TX USA;

Karolinska Inst Karolinska Univ Hosp Dept Med Rheumatol Unit Stockholm Sweden;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis [J] . Parodis I., Ding H., Zickert A., Scandinavian journal of rheumatology . 2017,第4期

机译：血清可溶性肿瘤坏死因子受体-2（STNFR2）作为肾组织损伤的生物标志物和狼疮性肾炎的长期肾果菌
2. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis [J] . Ant?nio L. Teixeira, Cynthia Azeredo Cordeiro, Fernando Oréfice, Brazilian Journal of Infectious Diseases . 2012,第6期

机译：活动性弓形体视网膜脉络膜炎患者血清可溶性肿瘤坏死因子受体2（sTNFR2）水平升高
3. SERUM ANEXELEKTO (AXL) AS A NOVEL BIOMARKER OF RENAL ACTIVITY, TREATMENT RESPONSE AND LONG-TERM OUTCOME IN PATIENTS WITH LUPUS NEPHRITIS [J] . Parodis I., Ding H., Zickert A., Clinical and experimental rheumatology . 2016,第4Suppla99期

机译：血清天疱疮（AXL）作为狼疮性肾炎患者肾脏活动，治疗反应和长期结局的新型生物标志物
4. Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis [O] . Vinicius Domingues, Benjamin A Levinson, Nicole Bornkamp, 2018

机译：1岁时血清白蛋白可预测狼疮性肾炎的长期肾结局
5. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis [O] . Thais Fontes Bessa, Cynthia Azeredo Cordeiro, Roberto Martins Gonçalves, 2012

机译：活动性弓形性视网膜脉络膜炎患者血清可溶性肿瘤坏死因子受体-2（sTNFR2）水平升高

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

摘要

著录项

相似文献

相关主题

期刊订阅